Liza-Marie Johnson, MD, MPH, MSB

Liza-Marie Johnson, MD, MPH, MSB

  • Program Director, Hospitalist Medicine
  • Staff Physician, Hospitalist Medicine Program
  • Chair and Bioethics Consultant, Hospital Ethics Committee


BA – Vassar College (2000)
MD – Tulane School of Medicine (2006)
MPH – Tulane School of Public Health & Tropical Medicine (2006)
MSB – Union Graduate College and the Icahn School of Medicine at Mount Sinai

Internship/Residency – Tufts Medical Center, Boston, MA
Fellowship (Pediatric Hematology/Oncology) – St. Jude Children’s Research Hospital

Honors & Awards

  • 2015 National Institutes of Health, OBSSR/NHLBI Summer Institute Award Recipient
  • 2014 National Institutes of Health, Loan Repayment Program Award Recipient
  • 2012 American Academy of Hospice and Palliative Medicine Research Scholar

Research Interests

  • Communication and Decision Making in Pediatric Oncology
  • Ethical Issues in Genomic Sequencing in Pediatrics
  • Clinical Ethics Consultation in Pediatrics
  • Research Ethics
  • Quality Improvement in Ambulatory/Urgent Care Pediatric Oncology

Selected Publications

Johnson LM, Unguru Y. Recruiting Children for Clinical Trials:  Lessons from Pediatric Oncology. Am J Bioeth 15(11): 24-26, 2015.

Johnson LM, Leek AC, Drotar D, Noll RB, Rheingold SR, Kodish ED, Baker JN. Practical Communication Guidance to Improve Phase I Informed Consent Conversations and Decision-Making in Pediatric Oncology. Cancer 121(14):2439-48, 2015.

Johnson LM, Church CL, Metzger M, Baker JN. Ethics Consultation in Pediatrics: Long-Term Experience from a Pediatric Oncology Center. Am J Bioeth 15(5):3-17, 2015.

Weaver M, Johnson LM. International Child Health Competencies. JAMA Pediatr 169(7):621-622, 2015.

Baker JN, Levine DR, Hinds PS, Weaver MS, Cunningham MJ, Johnson LM, Anghelescu D, Mandrell B, Gibson DV, Jones B, Wolfe J, Feudtner C, Freibert S, Carter B, Kane JR. Research Priorities in Pediatric Palliative Care. J Pediatr 167(2):467-70.e3, 2015.

Johnson LM and Sanchez AM (co-first authors), Kane JR, Kasow KA, Quintana Y, Barfield R, Church CL, Hester M, Baker JN. Ethical Decision Making About End-of-life Care Issues by Pediatric Oncologists in Economically Diverse Settings. J Pediatr Hematol Oncol 37(4):257-63, 2015.

Levine DR, Johnson LM, Mandrell B, Yang J, West N, Hinds PS, Baker JN. Does phase 1 trial enrollment preclude quality end‐of‐life care? Phase 1 trial enrollment and end‐of‐life care characteristics in children with cancer. Cancer 121(9):1508-1512, 2015.

Zaidi A, Johnson LM, Church CL, Gomez-Garcia WC, Popescu M, Margolin J, Ribeiro R. Management of Concurrent Pregnancy and Acute Lymphoblastic Malignancy in Teenaged Patients. Two Illustrative Cases and Review of the Literature. J Adolesc Young Adult Oncol 3(4):160-175, 2014.

Johnson LM, Snaman JM, Cupit MC, Baker JN. Review Article: End of Life Care for Hospitalized Children. Pediatr Clin North Am 61(4):835-854, 2014.

Johnson LM, Levine D. Allocation of Drugs in Short Supply. Virtual Mentor 15:645-648, 2013.

Johnson LM, Feudtner C, Baker JN. Minimally Conscious Assumptions and Dangerous Decision-making Inferences. AJOB Neurosci 4(1):61-63, 2013. 

Johnson LM, Church CL, Walsh M, Baker JN. Clinically Significant? Depends Who You Ask. Am J Bioeth (10):18-20, 2012.

Anghelescu DL, Hamilton H, Faughnan LG, Johnson LM, and Baker JN.  Pediatric Palliative Sedation Therapy with Propofol: Recommendations Based on Experience in Children with Terminal Cancer. J Palliat Med 15(10):1082-90, 2012.

Johnson LM, Spraker HL, Coleman JL, Baker JN. An unusual case of Ogilvie Syndrome in a pediatric oncology patient with progressive incurable cancer who failed treatment with neostigmine. J Palliat Med 15(9):1042-6, 2012.

Last update: January 2016